Cargando…

No increase in small-solute transport in peritoneal dialysis patients treated without hypertonic glucose for fifty-four months

BACKGROUND: Glucose is widely used as an osmotic agent in peritoneal dialysis (PD), but exerts untoward effects on the peritoneum. The potential protective effect of a reduced exposure to hypertonic glucose has never been investigated. METHODS: The cohort of PD patients attending our center which ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pagniez, Dominique, Duhamel, Alain, Boulanger, Eric, Lessore de Sainte Foy, Celia, Beuscart, Jean-Baptiste
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580320/ https://www.ncbi.nlm.nih.gov/pubmed/28859606 http://dx.doi.org/10.1186/s12882-017-0690-7

Ejemplares similares

Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2012)

Registration on the Renal Transplantation Waiting List and Mortality on Dialysis: an Analysis of the French REIN Registry Using a Multi-state Model
por: Beuscart, Jean-Baptiste, et al.
Publicado: (2015)

Hyperglycemic Crisis in an Anuric Peritoneal Dialysis Patient with Profound and Symptomatic Hypertonicity
por: Gibb, James, et al.
Publicado: (2018)

Regimen-related Mortality Risk in Patients Undergoing Peritoneal Dialysis Using Hypertonic Glucose Solution: A Retrospective Cohort Study
por: Sujimongkol, Chinakorn, et al.
Publicado: (2018)

Peritoneal dialysis-related peritonitis: challenges and solutions
por: Salzer, William L
Publicado: (2018)

Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection
por: Faure, Emmanuel, et al.
Publicado: (2016)

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions
por: Kussmann, Manuel, et al.
Publicado: (2019)

Stability and compatibility of antibiotics in peritoneal dialysis solutions
por: So, Simon Wai Yin, et al.
Publicado: (2022)

Early utilization of hypertonic peritoneal dialysate and subsequent risks of non-traumatic amputation among peritoneal dialysis patients: a nationwide retrospective longitudinal study
por: Lin, Shih-Yi, et al.
Publicado: (2013)

Peritoneal Fluid Transport rather than Peritoneal Solute Transport Associates with Dialysis Vintage and Age of Peritoneal Dialysis Patients
por: Waniewski, Jacek, et al.
Publicado: (2016)

Compatibility of aztreonam in four commercial peritoneal dialysis fluids
por: Tobudic, Selma, et al.
Publicado: (2020)

Increased peritoneal permeability at peritoneal dialysis initiation is a potential cardiovascular risk in patients using biocompatible peritoneal dialysis solution
por: Hamasaki, Yoshifumi, et al.
Publicado: (2014)

Small-volume hypertonic saline/pentastarch improves ileal mucosal microcirculation in experimental peritonitis
por: Assadi, Abdelnasser, et al.
Publicado: (2012)

Compatibility of fosfomycin with different commercial peritoneal dialysis solutions
por: Kussmann, M., et al.
Publicado: (2017)

Challenges and possible solutions to peritoneal dialysis use in Nigeria
por: Ajayi, Samuel, et al.
Publicado: (2020)

Is Assisted Peritoneal Dialysis a Solution for Northern Manitoba?
por: Lavoie, Josée G., et al.
Publicado: (2019)

Glycine improves peritoneal vasoreactivity to dialysis solutions in the elderly
por: Zakaria, El Rasheid, et al.
Publicado: (2019)

Unfavorable Effects of Peritoneal Dialysis Solutions on the Peritoneal Membrane: The Role of Oxidative Stress
por: Roumeliotis, Stefanos, et al.
Publicado: (2020)

Comparison of peritoneal transport characteristics at the second week and at six months of peritoneal dialysis commencement
por: Balasubramaniyam, R., et al.
Publicado: (2013)

Survival of Peritoneal Membrane Function on Biocompatible Dialysis Solutions in a Peritoneal Dialysis Cohort Assessed by a Novel Test
por: Balafa, Olga, et al.
Publicado: (2021)

Competing risk of death and end-stage renal disease in incident chronic kidney disease (stages 3 to 5): the EPIRAN community-based study
por: Ayav, Carole, et al.
Publicado: (2016)

The calcium concentration of peritoneal dialysis solution modifies levels of key mediators of peritoneal fibrosis
por: Miao, Chusheng, et al.
Publicado: (2020)

Resolution of severe eosinophilic peritonitis in a patient on continuous ambulatory peritoneal dialysis by changing from Dianeal peritoneal dialysis solution to Stay-Safe Balance solution: a case report
por: Chan, Zi, et al.
Publicado: (2022)

The impact of peritoneal dialysis-related peritonitis on mortality in peritoneal dialysis patients
por: Ye, Hongjian, et al.
Publicado: (2017)

ABNORMAL PROTOPLASMIC PATTERNS AND DEATH IN SLIGHTLY HYPERTONIC SOLUTIONS
por: Osterhout, W. J. V.
Publicado: (1948)

Efflux of Red Cell Water into Buffered Hypertonic Solutions
por: Olmstead, Edwin G.
Publicado: (1960)

On the Inhibition of Muscle Contraction Caused by Exposure to Hypertonic Solutions
por: Miyamoto, M., et al.
Publicado: (1972)

Loss of the Plateau of the Cardiac Action Potential in Hypertonic Solutions
por: Hermsmeyer, Kent, et al.
Publicado: (1972)

Development and Evaluation of a Chloramphenicol Hypertonic Ophthalmic Solution
por: Jithan, A. V., et al.
Publicado: (2008)

Renal protection in sepsis: Is hypertonic sodium (lactate) the solution?
por: Honore, Patrick M., et al.
Publicado: (2019)

Competing-risk analysis of death and dialysis initiation among elderly (≥80 years) newly referred to nephrologists: a French prospective study
por: Faller, Bernadette, et al.
Publicado: (2013)

Taurolidine Peritoneal Dialysis Catheter Lock to Treat Relapsing Peritoneal Dialysis Peritonitis
por: Alvarez Nadal, Marta, et al.
Publicado: (2020)

Peritoneal Dialysis
por: Pyper, R. A.
Publicado: (1948)

Peritoneal Dialysis
por: Taskapan, Hulya, et al.
Publicado: (2011)

A New Peritoneal Dialysis Solution Containing L-Carnitine and Xylitol for Patients on Continuous Ambulatory Peritoneal Dialysis: First Clinical Experience
por: Rago, Carmela, et al.
Publicado: (2021)

Sex Modulates Cardiovascular Effects of Icodextrin-Based Peritoneal Dialysis Solutions
por: Paniagua, Ramón, et al.
Publicado: (2022)

Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions
por: Cernaro, Valeria, et al.
Publicado: (2023)

Tension in Isolated Frog Muscle Fibers Induced by Hypertonic Solutions
por: Lännergren, J., et al.
Publicado: (1973)

Structural Alterations in Nerve Fibers Produced by Hypotonic and Hypertonic Solutions
por: Robertson, J. David
Publicado: (1958)

Operating Room Use of Hypertonic Solutions: A Clinical Review
por: Azoubel, Gustavo, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ln6apagfujkna9dq4b4ouqug81